Case reports describe fatal intracerebral bleeding in a patient taking
Ginkgo biloba with
ibuprofen, and prolonged bleeding and subdural haematomas in a patient taking
Ginkgo biloba with rofecoxib.
The evidence from these reports is too slim to forbid patients taking aspirin or
NSAIDs and
Ginkgo biloba concurrently, but some do recommend caution. Medical professionals should be aware of the possibility of increased bleeding tendency with
Ginkgo biloba and monitor patients appropriately.